Clinical Science
Chairs: Ashim Sinha & Michael d'Emden
Glycemic Control and Treatment Satisfaction in Type 2 Diabetes: Basal Plus compared with Biphasic Insulin in the LANSCAPE Trial (#78)
4:00 PM
What really happens when patients with Type 2 diabetes (T2DM) are commenced on insulin –longitudinal changes in HbA1c from initiation to 4 years - from the Australian S4S-DINGO – Diabetes Informatics Group (#79)
4:15 PM
Predictors of good blood glucose control in people receiving biphasic insulin aspart 30 premix insulin: data from the A1chieve study (#80)
4:30 PM
Improved glycaemic control without increased hypoglycaemia incidence and weight gain with insulin-vildagliptin combination therapy in Asian patients with type 2 diabetes (#81)
5:00 PM
Exenatide once weekly: Sustained glycaemic and weight control through 3 years compared with insulin glargine (#82)
5:15 PM